Editas Medicine (LTS:0IFK) 3-Year Book Growth Rate : -12.10% (As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Editas Medicine 3-Year Book Growth Rate?

Editas Medicine's Book Value per Share for the quarter that ended in Sep. 2024 was $2.13.

During the past 12 months, Editas Medicine's average Book Value per Share Growth Rate was -51.80% per year. During the past 3 years, the average Book Value per Share Growth Rate was -12.10% per year. During the past 5 years, the average Book Value per Share Growth Rate was -0.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 11 years, the highest 3-Year average Book Value per Share Growth Rate of Editas Medicine was 18.70% per year. The lowest was -12.10% per year. And the median was 8.70% per year.

Competitive Comparison of Editas Medicine's 3-Year Book Growth Rate

For the Biotechnology subindustry, Editas Medicine's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Editas Medicine's 3-Year Book Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Editas Medicine's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Editas Medicine's 3-Year Book Growth Rate falls into.

Editas Medicine 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Editas Medicine (LTS:0IFK) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Editas Medicine 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Editas Medicine's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Editas Medicine Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Editas Medicine Inc (LTS:0IFK) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

EDIT:USA 8EM:Germany

Address

11 Hurley Street, Cambridge, MA, USA, 02141

Website

https://www.editasmedicine.com

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.

Editas Medicine Headlines

No Headlines